Influenza News and Research

Latest Influenza News and Research

RSV found to cause more emergency department visits and hospitalizations than seasonal flu

Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public. However, an analysis from Children's Hospital Boston, based on patients seen in its emergency department (ED) during several recent flu seasons, shows that another virus - respiratory syncytial virus (RSV) - takes a substantially greater disease toll among young children than does seasonal flu.

23 Nov 2009

Compliance directive issued to protect health care workers from 2009 H1N1 influenza A virus

For the protection of frontline health care and emergency medical workers at high risk of infection, the U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) today issued a compliance directive to ensure uniform procedures when conducting inspections to identify and minimize or eliminate high to very high risk occupational exposures to the 2009 H1N1 influenza A virus.

21 Nov 2009

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October: Quest Diagnostics

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services.

From Quest Diagnostics 21 Nov 2009

First nationwide human immunology registry for infectious disease research

RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases.

21 Nov 2009

Evidence does not connect H1N1 vaccine to patient deaths, WHO says

The deaths of 41 people from six countries who had received the H1N1 (swine flu) vaccine were not directly linked to the vaccine, the WHO said Thursday, the Associated Press/MSNBC reports (11/19).

20 Nov 2009

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.

20 Nov 2009

Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report

Only about 1 in 4 Americans aged 50-64 regularly take advantage of preventive services such as screenings and immunizations, according to a report from the Centers for Disease Control and Prevention in collaboration with AARP and the American Medical Association (AMA).

20 Nov 2009

LAIV and TIV vaccines appear to offer protection against A/H1N1 virus

Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza pandemic. However, the benefit was largely attributed to the youngest age group. The finding emerges from an evaluation of medical encounters and seasonal influenza immunization of U.S. military service members.

20 Nov 2009

"EurSafety Health-net" launched to fight hospital acquired MRSA infection

On November 19, 2009, the kick-off meeting for the Euregio-project "EurSafety Health-net" has taken place. EurSafety Health-net is the follow-up of EUREGIO MRSA-net, that, according to the Robert Koch Institute, gained some sort of model character all over the nation when talking about prevention of hospital acquired MRSA infection. Besides the protection against infection, the main goal of this new project is to strengthen the patients' safety on both sides of the border.

20 Nov 2009

H1N1: Bridging the knowledge gap

A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. Infectious diseases specialist Leonard Mermel, DO, medical director of infection control for Rhode Island Hospital, looks at the ongoing debate in light of the H1N1 pandemic, what past research tells us about the spread of influenza, and what is missing in the debate. His commentary is currently available in an online first edition.

20 Nov 2009

BioCryst Pharmaceuticals declares proposed public offering of common stock

BioCryst Pharmaceuticals, Inc. today announced the pricing of a public offering of 5,000,000 shares of its common stock at $9.75 per share, resulting in gross proceeds of $48.75 million.

19 Nov 2009

High prevalence of asthma among children with H1N1

A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu.

19 Nov 2009

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic.

19 Nov 2009

DxNA announces successfull evaluation of its GeneSTAT PCR system

DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.

19 Nov 2009

Exaggerated responses of immune system explain elders’ susceptibility to viral infections

Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. Published in the November 19 Cell Host & Microbe, the study bucks the general belief that declining immune responses are to blame for susceptibility to viral infections.

19 Nov 2009

NPSF supports obligatory flu vaccination for healthcare workers

The National Patient Safety Foundation recognizes vaccine-preventable diseases as a matter of patient safety and supports mandatory influenza vaccination of health care workers to protect the health of patients, health care workers, and the community.

19 Nov 2009

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.

19 Nov 2009

MMR Information Systems and Unis-Tonghe Technology enter into a definitive agreement

MMR Information Systems, Inc., and Unis-Tonghe Technology (Zhengzhou) Co., Ltd, announced that they will enter into a definitive agreement by the end of this year to form a joint venture to build a customized version of MMR's proprietary personal health record ("PHR") services (www.mymedicalrecords.com) and professional document imaging and management solutions in China.

19 Nov 2009

Why avian flu virus has not caused a pandemic?

Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE.

19 Nov 2009

People with egg allergy can have H1N1 flu vaccine in graded doses

As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation.

19 Nov 2009

Influenza News and Research

Latest Influenza News and Research

RSV found to cause more emergency department visits and hospitalizations than seasonal flu

Compliance directive issued to protect health care workers from 2009 H1N1 influenza A virus

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October: Quest Diagnostics

First nationwide human immunology registry for infectious disease research

Evidence does not connect H1N1 vaccine to patient deaths, WHO says

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report

LAIV and TIV vaccines appear to offer protection against A/H1N1 virus

"EurSafety Health-net" launched to fight hospital acquired MRSA infection

H1N1: Bridging the knowledge gap

BioCryst Pharmaceuticals declares proposed public offering of common stock

High prevalence of asthma among children with H1N1

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

DxNA announces successfull evaluation of its GeneSTAT PCR system

Exaggerated responses of immune system explain elders’ susceptibility to viral infections

NPSF supports obligatory flu vaccination for healthcare workers

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

MMR Information Systems and Unis-Tonghe Technology enter into a definitive agreement

Why avian flu virus has not caused a pandemic?

People with egg allergy can have H1N1 flu vaccine in graded doses

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Influenza News and Research

Latest Influenza News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in